Evidence mapPaperPMID 35528003Full record

ArticleFrontiers in endocrinology2022

Towards the Integration of an Islet-Based Biosensor in Closed-Loop Therapies for Patients With Type 1 Diabetes.

Loïc Olçomendy, Louis Cassany, Antoine Pirog, Roberto Franco, Emilie Puginier, Manon Jaffredo, David Gucik-Derigny, Héctor Ríos, Alejandra Ferreira de Loza, Julien Gaitan and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Islets-on-Chip: A Tool for Real-Time Assessment of Islet Function Prior to Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Loïc OlçomendyUniv. Bordeaux, CNRS, Bordeaux INP, IMS, UMR 5218, Talence, France.
Louis CassanyUniv. Bordeaux, CNRS, Bordeaux INP, IMS, UMR 5218, Talence, France.
Antoine PirogUniv. Bordeaux, CNRS, Bordeaux INP, IMS, UMR 5218, Talence, France.
Roberto FrancoTecnológico Nacional de México/I.T. La Laguna, Torreón, Mexico.
Emilie PuginierUniv. Bordeaux, CNRS, CBMN, UMR 5248, Pessac, France.
Manon JaffredoUniv. Bordeaux, CNRS, CBMN, UMR 5248, Pessac, France.
David Gucik-DerignyUniv. Bordeaux, CNRS, Bordeaux INP, IMS, UMR 5218, Talence, France.
Héctor RíosTecnológico Nacional de México/I.T. La Laguna, Torreón, Mexico.
Alejandra Ferreira de LozaCátedras CONACYT, Ciudad de México, Mexico.
Julien GaitanUniv. Bordeaux, CNRS, CBMN, UMR 5248, Pessac, France.
Matthieu RaouxUniv. Bordeaux, CNRS, CBMN, UMR 5248, Pessac, France.
Yannick BornatUniv. Bordeaux, CNRS, Bordeaux INP, IMS, UMR 5218, Talence, France.
Bogdan CatargiUniv. Bordeaux, CNRS, CBMN, UMR 5248, Pessac, France.
Jochen LangUniv. Bordeaux, CNRS, CBMN, UMR 5248, Pessac, France.
David HenryUniv. Bordeaux, CNRS, Bordeaux INP, IMS, UMR 5218, Talence, France.
Sylvie RenaudUniv. Bordeaux, CNRS, Bordeaux INP, IMS, UMR 5218, Talence, France.
Jérôme CieslakUniv. Bordeaux, CNRS, Bordeaux INP, IMS, UMR 5218, Talence, France.
Centre National de la Recherche Scientifique · FRTecnológico Nacional de México · MXSecretaría de Ciencia, Humanidades, Tecnología e Innovación · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In diabetes mellitus (DM) treatment, Continuous Glucose Monitoring (CGM) linked with insulin delivery becomes the main strategy to improve therapeutic outcomes and quality of patients' lives. However, Blood Glucose (BG) regulation with CGM is still hampered by limitations of algorithms and glucose sensors. Regarding sensor technology, current electrochemical glucose sensors do not capture the full spectrum of other physiological signals,

Indexed as

Biosensing TechniquesDiabetes Mellitus, Type 1Blood GlucoseBlood Glucose Self-MonitoringHumansHypoglycemic AgentsInsulinInsulin Infusion SystemsUnited StatesBlood GlucoseHypoglycemic AgentsInsulinartificial pancreasbiosensorclosed-loop simulationinsulin therapymicro-electrode arraypancreatic isletstype 1 diabetes

Identifiers

PMID35528003
PMCPMC9072637
OpenAlexW4224278488

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.